Immuno-Oncology 360

Imaging in clinical trials has seen tremendous growth as evidenced by the number of trials initiated over the past two decades. Additionally, imaging data is increasingly used as the primary endpoint for some related trials. Put our expertise in drug, device and biologic imaging to work for you. At IO360 Immuno-Oncology clinical trial leaders will cover design trial, clinical operations, and the latest outcomes learned at this event. A wide range of emerging technologies will be covered, including ERT’s presentation on Advanced Imaging Technology which has become a hot topic in the industry.

Join Amit Vasanji, Chief Technology Officer, Imaging, ERT on February 7th during the 4:30 pm Imaging Plenary session for his presentation ‘Overcoming Imaging Challenges Through Technology.’ Amit will discuss how to overcome imaging challenges by presenting strategies to minimize risk in your studies. Stop by booth #7 to meet with Amit and the Imaging team to discuss imaging solutions.

Can’t make it? Click here to learn how ERT Advanced Imaging Technology can minimize manual errors and bias while maximizing visibility.